Chardan's 6th Annual Genetic Medicines Conference | Solid Biosciences Inc.

Skip to main navigation

IR Navigation

Overview
News & Events
Governance
Financial Information
- SEC Filings
- Annual Report & Proxy Materials
Stock Information
Investor Resources

« Solidbio.com

Chardan's 6th Annual Genetic Medicines Conference

Oct 4 1:00 PM EDT

Listen to Webcast

Footer Links

Contact Us
Privacy
Terms and Conditions

© 2023 Solid Biosciences Inc. All rights reserved.

Solid Biosciences Inc., is a Charlestown, MA-based life science company committed to solving Duchenne muscular dystrophy and improving the lives of patients. Solid is currently developing gene therapies, disease modifying therapies and assistive devices, all targeting the many facets of the disease.

The characterization of the discovery and development efforts on this website, as well as the expectations associated with them, are reflective of the current state of development and may change as the Company progresses.